Speaker: Professor Clive Prestidge, Clinical and Health Sciences and Cancer Research Institute, University of South Australia
Title: Nanocarriers to enable the effective performance of antimicrobials and advancing anti-infection therapy
Chair: Associate Professor Sarah Vreugde, ENT Surgery, The University of Adelaide and the Basil Hetzel Institute for Translational Health Research, TQEH
Zoom ID is 854 2337 0315 Password 939191 or click here for direct link
Speaker biography: Clive is the University of South Australia’s Professor of Pharmaceutical Science; he leads the internationally recognised Nanostructure and Drug Delivery research group and is Director for the newly established Centre for Pharmaceutical Innovation. He has an extensive track record in the development of nano-biomaterials for outcomes in Health and Medicine. His research broadly focuses on nanomaterials for drug delivery, with specific focus on lipid-based nanoparticles for chemotherapy, overcoming clinical infections and vaccines. He has supervised over 40 PhD students and authored over 250 international journal articles. He is an inventor of several technology platforms for drug delivery, gut health, anti-obesity and infection control, and has been extensively involved in patenting, licencing, spin off companies and partnering with industry to advance commercialisation of these technologies.
